Developers of vaporizers for migraines and asthma will need to convince skeptics
By Emma Rumney LONDON (Reuters) – A handful of North American companies that see the potential of e-cigarette-like devices to ease respiratory conditions such as migraines and asthma have a long way to go to convince health authorities and patients that their products could be the future of inhaled medicine. Two companies, Qnovia and MIIST… Read More »